Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Lyophilised haemostat platelet derivatives - Cellphire

Next Previous
X
Search
Drug Profile

Lyophilised haemostat platelet derivatives - Cellphire

Alternative Names: Freeze-dried platelets - Cellphire; Thrombosomes

Latest Information Update: 16 May 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Cellphire
  • Class Blood products and substitutes; Cell therapies
  • Mechanism of Action Blood coagulation stimulants; Cell replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Acute radiation syndrome
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase II Thrombocytopenia

Most Recent Events

  • 11 Apr 2024 Cellphire Therapeutics completes phase-II clinical trials in Thrombocytopenia in Denmark (IV) (NCT05771831)
  • 21 Mar 2024 Cellphire completes an expanded-access programme for Thrombocytopenia in USA (IV, Infusion) (NCT04619108)
  • 22 May 2023 Cellphire Therapeutics terminates a phase II trial in Thrombocytopenia in USA, Norway and Israel (IV) due to loss of funding for the indication from the Biomedical Advanced Research and Development Authority (NCT04631211)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top